

Cover Story
Capitol HillFree
By Matthew Bin Han Ong
Women who report sexual misconduct to NIH may find that their complaints have a limited shelf life—these complaints may become null, or at least ineligible for “even a cursory review” once perpetrators cut ties with NIH.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Christine Lovly to lead City of Hope’s new national thoracic oncology program
- FDA to remove black box warnings on hormone therapy for menopause
Trump-era “gold standard science” is not to be confused with gold standard of scientific evidence - Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- Rick Pazdur’s CDER appointment comes at exactly the right moment for FDA
- Smoldering multiple myeloma: Rethinking the waiting game
- Richard Pazdur, a respected insider with a plan to reengineer FDA, steps in as CDER director















